NKTREUR Nektar Therapeutics

held by 1 manager in Q2 2021

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.43%	6 mo	—	$17M	1,000,000

Search